Tokenized Securities Market Projected to Reach $45T by 2030

A lending protocol generated **$224,000 in operational funding** from a $1M treasury position using [Enzyme Myso](https://enzyme.finance/products/myso), achieving a **24% annual yield** through systematic covered call options. **Key highlights:** - Strategy involved writing covered calls on existing token holdings - Zero liquidation risk throughout the process - No tokens were sold to generate the income - Demonstrates alternative treasury management approach The protocol has distributed over **$2M in premiums** through the Enzyme Myso platform, which enables users to create, trade, and manage on-chain options either through automated strategies or over-the-counter arrangements. This approach offers protocols a way to generate operational income from treasury assets while maintaining their token positions and avoiding downside liquidation scenarios common in other yield strategies.

Binance announced the delisting of MLN without prior notice to Enzyme or explanation. The company clarified the decision is **not related to operational concerns** and MLN remains on other major exchanges. **Key highlights:** - Enzyme reports strongest performance in 9-year history - Onyx platform launched Q4 2025 with 10+ asset managers onboarded - Products include tokenized hedge funds, gold trackers, private credit, and money market funds - Onyx AUT exceeds historical protocol with revenues at all-time highs - April 2026 marked strongest month ever **Recent developments:** - Cross-chain deposits - Synchronous subscriptions - NAV automation - Integrations with Octav and 1Token - Upcoming extensions to Canton and Rayls Enzyme emphasized continued commitment to building decentralized infrastructure for next-generation financial markets despite challenging market conditions.

**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)

**Multi-chain complexity solved**: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers. **Automated data sourcing**: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from: - On-chain sources - Centralized finance platforms - Traditional financial systems **Pain point addressed**: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms. **Verification built-in**: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.

Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)